1 study found for:    ACNS1022
Show Display Options
Rank Status Study
1 Recruiting Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Conditions: Neurofibromatosis Type 1;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway Glioma
Intervention: Drug: lenalidomide

Indicates status has not been verified in more than two years